查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1570849

止瀉藥市場：按藥物類型、治療類型、分銷管道、治療類型分類 - 全球預測 2025-2030

Antidiarrhoeals Market by Drug Type (Bismuth Subsalicylate, Diphenoxylate, Loperamide), Treatment Type (Over-the-counter (OTC) Drugs, Prescription Drugs), Distribution Channel, Disease Type - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年止瀉藥市值為38.4億美元，預計到2024年將達到40.3億美元，複合年成長率為5.21%，到2030年將達到54.9億美元。

止瀉藥是用來緩解腹瀉症狀、控制脫水和恢復電解質平衡的藥物。這些藥物的需求是由多種潛在原因引起的，包括感染疾病、食物不耐症和慢性疾病。適用於急性和慢性病例，在醫院、診所和居家照護等醫療環境中至關重要。最終用途範圍包括直接消費者、醫療保健提供者和醫療機構。市場開拓主要受到全球胃腸道疾病盛行率不斷上升、新興國家健康意識提高和藥品取得範圍擴大的影響。潛在的機會包括開發針對特定病原體的新型止瀉藥、利用數位健康平台更好地管理患者以及擴大醫療需求未滿足的新興經濟體的市場影響佔有率。主要建議包括投資研究以確定創新成分和輸送系統，以及與科技公司建立策略夥伴關係以推動數位健康解決方案。

主要市場統計
基準年[2023] 38.4億美元
預測年份 [2024] 40.3億美元
預測年份 [2030] 54.9億美元
複合年成長率（%） 5.21%

挑戰包括嚴格的監管途徑、長期使用的潛在副作用以及學名藥的競爭導致價格壓力。社會向自然和草藥療法的轉變也可能對市場成長構成挑戰，需要全面的臨床試驗來證實其主張。創新治療領域應著重於個人化醫療，包括微生物組治療，並利用人工智慧進行預測診斷和針對患者的治療計畫。此外，整合遠端醫療有可能徹底改變止瀉病人參與和治療監測。

該市場的特點是競爭激烈，現有製藥公司佔據主導地位，而非專利製造商的進入不斷增加。全球對醫療保健系統中具有成本效益的解決方案的需求需要創新的經營模式，以平衡負擔能力與高品質的治療選擇。為了推動成長，公司應專注於其產品的可及性、差異化和永續性，以適應不斷變化的消費者需求和監管環境。

市場動態：揭示快速發展的止瀉藥市場的關鍵市場洞察

供需的動態交互作用正在改變止瀉藥市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，以及如何減輕消費行為及其對製造成本的影響及其對採購趨勢的影響。

波特五力：開拓止瀉藥市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解止瀉藥市場的外部影響

外部宏觀環境因素對止瀉藥市場的表現動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解止瀉藥市場的競爭狀況

對止瀉藥市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣止瀉藥市場供應商績效評估

FPNV定位矩陣是評估止瀉藥市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，描繪止瀉藥市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，止瀉藥市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭格局中的挑戰，利用新的商機並取得長期成功。

該報告提供了涵蓋關鍵焦點細分市場的全面市場分析。

1. 市場滲透率：對當前市場環境的詳細回顧。

2. 市場開拓：辨識新興市場的成長機會，評估現有產業的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢視市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 老年人消化器官系統健康問題增加
      • 消費者生活方式的變化和獲得醫療保健的意識增強
      • 增加對新興經濟體衛生基礎設施和研發的投資
    • 抑制因素
      • 藥物臨床分析相關的高成本
    • 機會
      • 針對特定族群的個人化醫療趨勢正在興起。
      • 非藥物解決方案的技術進步
    • 任務
      • 不同地區監管嚴格、標準不規範
  • 市場區隔分析
    • 藥物類型：洛哌丁胺作為急慢性腹瀉一線治療藥物的使用增加
    • 分銷管道：線上分銷管道在精通技術的消費者中越來越受歡迎
  • 波特五力分析
  • PESTLE分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章止瀉藥市場：依藥物類型

  • 介紹
  • 水楊酸鉍
  • 地芬諾酯
  • 洛哌丁胺
  • 口服補液鹽 (ORS)

第7章止瀉藥市場：依治療類型

  • 介紹
  • 非處方藥 (OTC)
  • 處方藥

第8章止瀉藥市場：依通路分類

  • 介紹
  • 離線
  • 線上

第9章止瀉藥市場：依疾病類型

  • 介紹
  • 急性腹瀉
  • 慢性腹瀉
  • 旅行者腹瀉

第10章美洲止瀉藥市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太止瀉市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東和非洲止瀉市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 百時美施貴寶公司透過收購 Mirati Therapeutics 擴大產品組合
  • 戰略分析和建議
Product Code: MRR-976C0ED91C3A

The Antidiarrhoeals Market was valued at USD 3.84 billion in 2023, expected to reach USD 4.03 billion in 2024, and is projected to grow at a CAGR of 5.21%, to USD 5.49 billion by 2030.

Antidiarrhoeals are medications used to alleviate symptoms of diarrhea, manage dehydration, and restore electrolyte balance. The need for these medications is driven by various underlying causes such as infections, food intolerances, and chronic diseases. They are applicable in both acute and chronic cases and are essential in healthcare settings, including hospitals, clinics, and at-home care. The end-use scope covers direct consumers, healthcare providers, and medical institutions. Market growth is primarily influenced by increasing global prevalence of gastrointestinal disorders, rising awareness about health, and the expansion of access to pharmaceuticals in developing regions. Potential opportunities lie in the development of novel antidiarrhoeal drugs targeting specific pathogens, leveraging digital health platforms for better patient management, and expanding market presence in emerging economies with unmet healthcare needs. Key recommendations include investing in research to identify innovative ingredients and delivery systems and forming strategic partnerships with technology firms to enhance digital healthcare solutions.

KEY MARKET STATISTICS
Base Year [2023] USD 3.84 billion
Estimated Year [2024] USD 4.03 billion
Forecast Year [2030] USD 5.49 billion
CAGR (%) 5.21%

Challenges include stringent regulatory pathways, possible side effects of long-term medication use, and generic competition leading to price pressures. Societal shifts towards natural and herbal remedies may also challenge market growth, necessitating comprehensive clinical trials to substantiate claims. Areas of innovation should focus on personalized medicine, including microbiome therapeutics, and harnessing artificial intelligence for predictive diagnoses and patient-specific treatment plans. Additionally, the integration of telemedicine could revolutionize patient engagement and therapy monitoring for antidiarrhoeals.

The market is characterized by its competitive nature, with established pharmaceutical companies dominating alongside increasing participation from generic manufacturers. The push for cost-effective solutions in healthcare systems globally calls for innovative business models that balance affordability and high-quality treatment options. To foster growth, businesses should focus on accessibility, differentiation, and sustainability in product offerings, aligning with the evolving consumer demands and regulatory landscapes.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Antidiarrhoeals Market

The Antidiarrhoeals Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing incidents of digestive health issues in the geriatric population
    • Growing awareness about lifestyle changes and healthcare access among consumers
    • Rising investments in healthcare infrastructure and R&D in developing economies
  • Market Restraints
    • High cost associated with clinical analysis of drugs
  • Market Opportunities
    • Rising trends of personalized medicine tailored to specific demographics
    • Technological advancements for non-pharmacological solutions
  • Market Challenges
    • Non-standardization of strict regulations and standards across various geographies

Porter's Five Forces: A Strategic Tool for Navigating the Antidiarrhoeals Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Antidiarrhoeals Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Antidiarrhoeals Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Antidiarrhoeals Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Antidiarrhoeals Market

A detailed market share analysis in the Antidiarrhoeals Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Antidiarrhoeals Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Antidiarrhoeals Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Antidiarrhoeals Market

A strategic analysis of the Antidiarrhoeals Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Antidiarrhoeals Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Actelion Pharmaceuticals Ltd, AstraZeneca PLC, Bayer AG, Bristol-Myers Squibb Company, Cipla Limited, Daiichi Sankyo Company, Limited, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline PLC, Henry Schein, Inc., Johnson & Johnson Services, Inc., Lupin Limited, Merck & Co., Inc., Novartis International AG, Perrigo Company PLC, Pfizer Inc., Procter & Gamble Company, Sanofi S.A., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Antidiarrhoeals Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Drug Type, market is studied across Bismuth Subsalicylate, Diphenoxylate, Loperamide, and Oral Rehydration Salts (ORS).
  • Based on Treatment Type, market is studied across Over-the-counter (OTC) Drugs and Prescription Drugs.
  • Based on Distribution Channel, market is studied across Offline and Online.
  • Based on Disease Type, market is studied across Acute Diarrhoea, Chronic Diarrhoea, and Traveller's Diarrhoea.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidents of digestive health issues in the geriatric population
      • 5.1.1.2. Growing awareness about lifestyle changes and healthcare access among consumers
      • 5.1.1.3. Rising investments in healthcare infrastructure and R&D in developing economies
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with clinical analysis of drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising trends of personalized medicine tailored to specific demographics
      • 5.1.3.2. Technological advancements for non-pharmacological solutions
    • 5.1.4. Challenges
      • 5.1.4.1. Non-standardization of strict regulations and standards across various geographies
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Drug Type: Growing use of loperamide in first-line treatment for acute and chronic diarrhea
    • 5.2.2. Distribution Channel: Increasing popularity of online distribution channels among tech-savvy consumers
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Antidiarrhoeals Market, by Drug Type

  • 6.1. Introduction
  • 6.2. Bismuth Subsalicylate
  • 6.3. Diphenoxylate
  • 6.4. Loperamide
  • 6.5. Oral Rehydration Salts (ORS)

7. Antidiarrhoeals Market, by Treatment Type

  • 7.1. Introduction
  • 7.2. Over-the-counter (OTC) Drugs
  • 7.3. Prescription Drugs

8. Antidiarrhoeals Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Offline
  • 8.3. Online

9. Antidiarrhoeals Market, by Disease Type

  • 9.1. Introduction
  • 9.2. Acute Diarrhoea
  • 9.3. Chronic Diarrhoea
  • 9.4. Traveller's Diarrhoea

10. Americas Antidiarrhoeals Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Antidiarrhoeals Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Antidiarrhoeals Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Bristol-Myers Squibb Company expanded its portfolio with the acquisition of Mirati Therapeutics
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Actelion Pharmaceuticals Ltd
  • 3. AstraZeneca PLC
  • 4. Bayer AG
  • 5. Bristol-Myers Squibb Company
  • 6. Cipla Limited
  • 7. Daiichi Sankyo Company, Limited
  • 8. Eli Lilly and Company
  • 9. F. Hoffmann-La Roche AG
  • 10. GlaxoSmithKline PLC
  • 11. Henry Schein, Inc.
  • 12. Johnson & Johnson Services, Inc.
  • 13. Lupin Limited
  • 14. Merck & Co., Inc.
  • 15. Novartis International AG
  • 16. Perrigo Company PLC
  • 17. Pfizer Inc.
  • 18. Procter & Gamble Company
  • 19. Sanofi S.A.
  • 20. Sun Pharmaceutical Industries Ltd.
  • 21. Takeda Pharmaceutical Company Limited
  • 22. Teva Pharmaceutical Industries Ltd.

LIST OF FIGURES

  • FIGURE 1. ANTIDIARRHOEALS MARKET RESEARCH PROCESS
  • FIGURE 2. ANTIDIARRHOEALS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ANTIDIARRHOEALS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS ANTIDIARRHOEALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS ANTIDIARRHOEALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES ANTIDIARRHOEALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES ANTIDIARRHOEALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC ANTIDIARRHOEALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC ANTIDIARRHOEALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ANTIDIARRHOEALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ANTIDIARRHOEALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ANTIDIARRHOEALS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. ANTIDIARRHOEALS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ANTIDIARRHOEALS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ANTIDIARRHOEALS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ANTIDIARRHOEALS MARKET DYNAMICS
  • TABLE 7. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY BISMUTH SUBSALICYLATE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY DIPHENOXYLATE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY LOPERAMIDE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY ORAL REHYDRATION SALTS (ORS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY OVER-THE-COUNTER (OTC) DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY ACUTE DIARRHOEA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY CHRONIC DIARRHOEA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ANTIDIARRHOEALS MARKET SIZE, BY TRAVELLER'S DIARRHOEA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS ANTIDIARRHOEALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES ANTIDIARRHOEALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC ANTIDIARRHOEALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA ANTIDIARRHOEALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM ANTIDIARRHOEALS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM ANTIDIARRHOEALS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM ANTIDIARRHOEALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM ANTIDIARRHOEALS MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. ANTIDIARRHOEALS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 191. ANTIDIARRHOEALS MARKET, FPNV POSITIONING MATRIX, 2023